Cite
MLA Citation
K. Dawson et al.. “Preliminary biomarker and pharmacokinetic analysis from the completed dose escalation part of the first-in-human Phase I study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF-A, in patients with advanced solid tumors.” European journal of cancer, vol. 69, n.d., pp. S133–. http://access.bl.uk/ark:/81055/vdc_100039473461.0x000034